Share This Page
Drugs in ATC Class A16AA
✉ Email this page to a colleague
Drugs in ATC Class: A16AA - Amino acids and derivatives
| Tradename | Generic Name |
|---|---|
| BETAINE | betaine |
| CARBAGLU | carglumic acid |
| CARGLUMIC ACID | carglumic acid |
| CARNITOR | levocarnitine |
| CARNITOR SF | levocarnitine |
| LEVOCARNITINE | levocarnitine |
| LEVOCARNITINE SF | levocarnitine |
| >Tradename | >Generic Name |
Showing 1 to 7 of 7 entries
A16AA Market Analysis and Financial Projection
The ATC class A16AA (amino acids and derivatives) represents a critical segment in pharmaceuticals and metabolic therapies, driven by innovation, expanding therapeutic applications, and shifting global market dynamics. Here’s a comprehensive analysis:
Market Dynamics
Growth Drivers
- Rising Demand in Therapeutics: Amino acids like levocarnitine, glutamine, and mercaptamine are pivotal for treating metabolic disorders, genetic deficiencies (e.g., primary carnitine deficiency), and complications of lipodystrophy[1]. The global amino acids market is projected to grow from $31.8 billion in 2024 to $42.8 billion by 2029 (CAGR: 6.1%)[6], with pharmaceutical applications driving accelerated adoption.
- Expanding Nutritional and Animal Feed Sectors: Lysine, methionine, and threonine dominate demand in animal feed, while sports nutrition and functional foods fuel growth in the food industry[3][6].
- Technological Advancements: Fermentation optimization, synthetic biology, and green chemistry are reducing production costs and improving scalability[3][6].
Key Market Players
| Leading companies include: | Company | Focus Area |
|---|---|---|
| Ajinomoto Co. | Glutamate, lysine production | |
| Evonik Industries | Methionine for animal feed | |
| PeptiDream | Novel amino acid derivatives for drug R&D[4] |
Challenges
- Raw Material Volatility: Dependence on corn, soy, and sugarcane derivatives exposes the market to price fluctuations[3].
- Regulatory Hurdles: Strict quality control (e.g., U.S. Pharmacopeia standards) and orphan drug designations (e.g., carglumic acid for urea cycle disorders[5]) complicate market entry[6][11].
Patent Landscape
Innovation Trends
- AgriFood Dominance: Over 3.5 million Agrifood patents were filed in 20 years, with 60% focused on AgriTech (e.g., IoT-enabled farming)[2]. However, A16AA-specific innovation leans toward:
- Enhanced Drug Efficacy: PeptiDream’s patent (US20230312479A1) for amino acid derivatives improving polypeptide binding affinity[4].
- Metabolic Engineering: CRISPR and synthetic biology for producing rare amino acids like mercaptamine[14].
Geographic Shifts
- U.S. Leadership: Leads international filings, but Asia-Pacific (notably China and India) shows rapid growth in domestic patents[2][6].
- Limited Globalization: Only 12% of Agrifood patents seek protection outside their home region, highlighting regional prioritization[2].
Regulatory and Clinical Developments
- Orphan Drug Designations: Carglumic acid (A16AA05) for urea cycle disorders and metreleptin for lipodystrophy underscore A16AA’s role in niche therapies[1][5].
- Clinical Trials: Over 376 trials for bispecific antibodies (many involving amino acid derivatives) launched in 2023 alone[10].
Future Outlook
- Personalized Medicine: Amino acids like glutamine (for sickle cell disease[1]) and betaine (for homocystinuria) are gaining traction in precision therapies[14].
- Sustainability Initiatives: Companies are adopting agricultural byproducts for amino acid synthesis to mitigate raw material risks[3][6].
"The surge in Agrifood patents reflects a global push to address food security, but therapeutic amino acids remain a high-growth niche." – WIPO Patent Landscape Report[2].
Key Takeaways
- A16AA’s market growth hinges on metabolic disorder treatments and sustainable production tech.
- Asia-Pacific’s patent surge signals shifting R&D power dynamics.
- Regulatory complexities and raw material dependencies remain critical challenges.
Sources: [1][2][3][4][5][6][14]
References
- https://atcddd.fhi.no/atc_ddd_index/?code=A16AA&showdescription=yes
- https://www.wipo.int/en/web/patent-analytics/w/news/2024/patent-landscape-report-on-agrifood
- https://www.futuremarketinsights.com/reports/amino-acids-market
- https://www.pharmaceutical-technology.com/data-insights/peptidream-files-patent-for-improving-binding-affinity-of-polypeptides-using-amino-acid-derivative/
- https://www.has-sante.fr/upload/docs/application/pdf/2014-06/carbaglu_en_ct12638_val.pdf
- https://www.globenewswire.com/news-release/2025/01/16/3010714/28124/en/Commercial-Amino-Acids-Markets-Report-2024-2029-Growing-Population-Driving-Demand-Increasing-Use-as-Nutraceuticals-Expanding-Uses-Fueling-Growth.html
- https://www.iqvia.com/-/media/iqvia/pdfs/belgium/sales-trends/2020/may-belgian-reg-med-best.pdf
- https://patents.google.com/patent/WO2018165504A1/en
- https://a16z.com/outclassed-the-battle-for-therapeutic-market-share/
- https://www.pharmasalmanac.com/articles/what-are-the-current-investment-trends-in-the-pharmaceutical-industry
- https://www.um.edu.mt/library/oar/bitstream/123456789/41616/1/Availability_of_medicinal_products_on_the_Maltese_market_as_affected_by_regulation_2016.pdf
- https://www.acclaimip.com/patent-landscaping/patent-landscape-analysis-uncovering-strategic-insights/
- https://www.mordorintelligence.com/industry-reports/finland-pharmaceutical-market
- https://sites.google.com/view/insight-nexusww/top-report/pharmaceutical-amino-acids-market-by-application
More… ↓
